The Russian invasion of Ukraine:

Implication for hematologists and oncologists

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

No modern war has been fought on the territory of a country with nuclear power facilities.

Today, the Russian troops have entered the territory of Ukraine.  This incursion is causing a substantial, immediate loss of lives on both sides of the conflict, but few people have considered other potential consequences of interest and concern to readers of The Cancer Letter. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert Peter Gale, MD, PhD, DSC(hc), FACP, FRCP, FRCPI(hon), FRSM, LHD, DPS
Visiting professor of haematology, Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.
Robert Peter Gale, MD, PhD, DSC(hc), FACP, FRCP, FRCPI(hon), FRSM, LHD, DPS
Visiting professor of haematology, Centre for Haematology Research, Department of Immunology and Inflammation, Imperial College London

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login